Ratings Bath & Body Works, Inc.

Equities

BBWI

US0708301041

Delayed Nyse Other stock markets 01:00:01 2024-07-03 pm EDT			5-day change	1st Jan Change
37.7 ^USD	-1.10%		-5.87%	-12.65%

Jun. 20	Bath & Body Works Insider Sold Shares Worth $1,992,120, According to a Recent SEC Filing	MT
Jun. 11	Transcript : Bath & Body Works, Inc. Presents at 4th Annual Evercore ISI Consumer and Retail Conference, Jun-11-2024 11:00 AM

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
The company's earnings growth outlook lacks momentum and is a weakness.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Other Specialty Retailers

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
BATH & BODY WORKS, INC.	-12.65%	8.42B		B
CK HUTCHISON HOLDINGS LIMITED	-9.44%	18.61B		B+
ULTA BEAUTY, INC.	-20.47%	18.59B		B-
E.L.F. BEAUTY, INC.	+39.96%	11.3B		C+
OLIVEDA INTERNATIONAL, INC.	+3,094.00%	7.83B	-	-
DOUGLAS AG	0.00%	2.08B	-	-
HONASA CONSUMER LIMITED	+10.41%	1.69B	-	-
POYA INTERNATIONAL CO., LTD.	-8.51%	1.59B		-
WALDENCAST PLC	-68.56%	435M		-
IFAMILYSC CO., LTD.	+162.74%	412M		-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes